M-Y. Mistou. I.C. Sutcliffe, and M. van Sorge. Bacterial glycobiology: rhamnose-containing cell wall polysaccharides in Gram-positive bacteria. 2016 FEMS Microbiol Rev Early online March 13 2016. (http://femsre.oxfordjournals.org/content/early/2016/03/13/femsre.fuw006.full?ijkey=EzLdDCuptFmSgop&keytype=ref)

Askarian, C. Ajayi, A-M. Hanssen, N.M. van Sorge, I. Pettersen, D.B. Diep, J.U.E. Sollid, M. Johannessen. The interaction between Staphylococcus aureus SdrD and desmoglein 1 is important for adhesion to host cells Sci Rep 2016; Feb 29; 6: 22134. (http://www.ncbi.nlm.nih.gov/pubmed/26924733)

L. van der Beek, Y. Le Breton, A.T. Ferenbach, R.N. Chapman, D.M.F. van Aalten, I. Navratilova, G-J. Boons, K. McIver, N.M. van Sorge, H.C. Dorfmueller. GacA is essential for Group A Streptococcus and defines a new class of monomeric dTDP-4-dehydrorhamnose reductases (RmlD). Mol Microbiol 2015; 98 (5): 946-962. (http://www.ncbi.nlm.nih.gov/pubmed/26278404)

J. Kim, B.M. Hancock, A. Bermudez, N. Del Cid, E. Reyes, N.M. van Sorge, X. Lauth, C. Smurthwaite, B. Hilton, A. Stotland, A. Banerjee, J. Buchanan, R. Wolkowicz, D. traver, K.S. Doran. Bacterial induction of Snail1 contributes to blood-brain barrier disruption. J Clin Invest 2015; 25 (6): 2473-83. (http://www.ncbi.nlm.nih.gov/pubmed/25961453)

M. van Sorge. An update on Group A Streptococcus pathogenesis and vaccine development. Tijdschrift voor Infectieziekten 2015; 10 (3): 65-72.

van Avondt, N.M. van Sorge, L. Meyaard. Bacterial immune evasion through manipulation of host inhibitory immune signaling. PLoS Pathog 2015 Mar 5; 11(3): e1004644. (http://www.ncbi.nlm.nih.gov/pubmed/25742647)

N.M. van Sorge*, Jason N. Cole*, Kirsten Kuipers, Ramy K. Aziz, Ana Kasirer-Friede, Leo Lin, Evelien T.M. Berends, Mark R. Davies, Gordon Dougan, Fan Zhang, Samira Dahesh, Laura Shaw, Jennifer Gin, Madeleine Cunningham, Joseph A. Merriman, Suzan H.M. Rooijakkers, Richard Malley, Mark J. Walker, Sanford J. Shattil, Patrick M. Schlievert, Biswa Choudhury, Victor Nizet. The classical Lancefield antigen of Group A Streptococcus is a virulence determinant with implications for vaccine design. Cell Host and Microbe. 2014; 15 (6): 729-40. * Authors contributed equally (http://www.ncbi.nlm.nih.gov/pubmed/24922575)

Askarian, N.M. van Sorge, M.Sangvik, F.C. Beasley, J.R. Henriksen, J.U.E. Sollid, J.A.G. van Strijp, V. Nizet, M. Johannessen. A Staphylococcal TIR-domain protein virulence factor blocks TLR2-mediated NF-kB signaling. Journal of Innate Immunity 2014; 6 (4): 485-98. (http://www.ncbi.nlm.nih.gov/pubmed/24481289)

Guichard, B. Cruz Moreno, B, Aguilar, N.M. van Sorge, J. Kuang, A. A. Kurkciyan, G.P. Pineton de Chambrun, Z. Wang, S. Hang, P. Watnick, D. F. McCole, V. Nizet, E. Bier. Cholera toxin disrupts exocyst-mediated trafficking to intestinal cell junctions. Cell Host and Microbe. 2013; 14 (3): 294-305. (http://www.ncbi.nlm.nih.gov/pubmed/24034615)

N.M. van Sorge, F.C. Beasley, I. Gusarov, D.J. Gonzalez, M. von Köckritz-Blickwede, S. Anik, A. Borkowski, P.C. Dorrestein, E. Nudler, and V. Nizet. Methicillin-resistant Staphylococcus aureus bacterial nitric oxide synthase affects antibiotic sensitivity and skin abscess development. Journal of Biological Chemistry. 2013; 288 (9): 6417-6426. (http://www.ncbi.nlm.nih.gov/pubmed/23322784)

J.N. Cole, R.K. Aziz, K. Kuipers, A.T. Timmer, V. Nizet, N.M. van Sorge. A conserved UDP-glucose dehydrogenase outside the hasABC operon contributes to capsule biogenesis in Group A Streptococcus. Journal of Bacteriology. 2012; 194 (22): 6154-61.(http://www.ncbi.nlm.nih.gov/pubmed/22961854)

N.M. van Sorge and K.S.Doran. Defense at the border: the blood-brain barrier versus bacterial foreigners. Future Microbiology. 2012: 7 (3); 383-94. (http://www.ncbi.nlm.nih.gov/pubmed/22393891)

T.R. Sheen, A. Jimenez, A. Banerjee, N.M. van Sorge and K.S. Doran. Serine-rich proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. Journal of Bacteriology 2011; 193 (24): 6834-42. (http://www.ncbi.nlm.nih.gov/pubmed/21984789)

N.M. van Sorge, P.A. Zialcita, S.H. Browne, D. Quach, D.G. Guiney, K.S. Doran. Penetration and activation of brain endothelium by Salmonella enteric serovar Typhimurium. Journal of Infectious Diseases 2011: 203 (3); 401-405 (http://www.ncbi.nlm.nih.gov/pubmed/21186258)

Piepers, M.D. Jansen, E.A. Cats, N.M. van Sorge, L.H. van den Berg, W-L. van der Pol. IVIG inhibits classical pathway activity and anti-GM1 IgM-mediated complement deposition in MMN. Journal of Neuroimmunology 2010: 229 (1-2); 256-262.(http://www.ncbi.nlm.nih.gov/pubmed/20920831)

A.Guichard, S.M. McGillivray*, B. Cruz Moreno*, N.M. van Sorge*, V. Nizet, E. Bier. Anthrax toxins cooperatively inhibit endocytic recycling by the Rab11/Sec15 exocyst. Nature 467 2010: 7317; 854-858. *Authors contributed equally (http://www.ncbi.nlm.nih.gov/pubmed/20944747)

A.Banerjee, N.M. van Sorge, S. Uchiyama, T.J. Mitchell, K.S. Doran. Activation of brain endothelium by pneumococcal neuraminidase NanA promotes bacterial internalization. Cellular Microbiology 2010: 12 (11); 1576-88. (http://www.ncbi.nlm.nih.gov/pubmed/20557315)

C.M. Ebrahimi, J.W. Kern, T. R. Sheen, M.A. Ebrahimi-Fardooee, N.M. van Sorge, O. Schneewind, K.S. Doran. Penetration of the blood-brain barrier by Bacillus anthracis requires the pXO1-encoded BslA protein. Journal of Bacteriology 2009: 191 (23); 7165-73. (http://www.ncbi.nlm.nih.gov/pubmed/19820089)

N.M. van Sorge, N.M. Bleumink, S.J. van Vliet, E. Saeland, W-L. van der Pol, Y. van Kooyk, J.P.M. van Putten. N-glycosylated proteins and distinct LOS glycoforms of Campylobacter jejuni target the human C-type lectin receptor MGL. Cellular Microbiology 2009: 11 (12); 1768-81. (http://www.ncbi.nlm.nih.gov/pubmed/19681908)

N.M. van Sorge, D.Quach, M.A. Gurney, P.M. Sullam, V. Nizet, K.S. Doran. The group B streptococcal Srr-1 glycoprotein mediates penetration of the blood-brain barrier. Journal of Infectious Diseases 2009: 199 (10); 1479-87. (http://www.ncbi.nlm.nih.gov/pubmed/19392623)

Sendi, L. Johansson, S. Dahesh, N.M. van Sorge, J. Darenberg, M. Norgren, J. Sjölin, V. Nizet, and A. Norrby-Teglund. Bacterial phenotype variants in Group B streptococcal toxic shock syndrome. Emerging Infectious Diseases 2009: 15(2); 223-32.(http://www.ncbi.nlm.nih.gov/pubmed/19193266)

Quach, N.M. van Sorge, S.A. Kristian, J.D. Bryan, D.W. Shelver, K.S. Doran. The CiaR response regulator in Group B Streptococcus promotes intracellular survival and resistance to innate immune defenses. Journal of Bacteriology 2009: 191(7); 2023-32. (http://www.ncbi.nlm.nih.gov/pubmed/19114476)

N.M. van Sorge, C.M. Ebrahimi, S.M. McGillivray, D. Quach, M. Sabet, D.G. Guiney, K.S. Doran. Anthrax toxins inhibit neutrophil signaling pathways in brain endothelium and contribute to the pathogenesis of meningitis. PLoS ONE 2009: 3 (8); e2964. (http://www.ncbi.nlm.nih.gov/pubmed/18698416)

Dahesh, M. Hensler, N.M. van Sorge, R.E. Gertz Jr., S. Schrag, V. Nizet, B.W. Beall. Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother. 2008: 52 (8); 2915-18. (http://www.ncbi.nlm.nih.gov/pubmed/18541727)

N.M. van Sorge, N. Yuki, M. Koga, K. Susuki, M.D. Jansen, C. van Kooten, J.H.J. Wokke, J.G.J. van de Winkel, W-L. van der Pol, L.H. van den Berg. Ganglioside-specific IgG and IgA in serum of patients with Guillain-Barré syndrome and Miller Fisher syndrome efficiently activate leukocytes. Journal of Neuroimmunology 2007: 182; 177-184. (http://www.ncbi.nlm.nih.gov/pubmed/17156858)

N.M. van Sorge, N. Yuki, M.D. Jansen, Y. Nishimoto, K. Susuki, M. Koga, J.H.J. Wokke, J.G.J. van de Winkel, L.H. van den Berg, W-L. van der Pol. Leukocyte and complement activation by GM1-specific antibodies is associated with acute motor axonal neuropathy in rabbits. Journal of Neuroimmunology 2007: 182; 116-123. (http://www.ncbi.nlm.nih.gov/pubmed/17161468)

N.M. van Sorge, W-L. van der Pol, M.D. Jansen, K.P.W. Geleijns, S. Kalmijn,  R.A.C. Hughes, J.H. Rees, J. Pritchard, C.A. Vedeler, K-M. Myhr, C. Shaw, I.N. van Schaik, J.H.J. Wokke, P.A. van Doorn, B.C. Jacobs, J.G.J. van de Winkel, L.H. van den Berg. Severity of Guillain-Barré syndrome is associated with Fcg ReceptorIII polymorphisms. Journal of Neuroimmunology 2005:162; 157-164. (http://www.ncbi.nlm.nih.gov/pubmed/15833371)

N.M. van Sorge, W-L. van der Pol, M.D. Jansen, L.H. van den Berg. Pathogenicity of anti-ganglioside antibodies in the Guillain-Barré syndrome. Autoimmunity reviews 2004: 3; 61-68. (http://www.ncbi.nlm.nih.gov/pubmed/15003189)

N.M. van Sorge, W-L. van der Pol, J.G.J. van de Winkel. FcgR polymorphisms: Implications for function, disease susceptibility and immunotherapy. Tissue Antigens 2003: 61; 189-202. (http://www.ncbi.nlm.nih.gov/pubmed/12694568)

N.M. van Sorge, L.H. van den Berg, K. Geleijns, J.A. van Strijp, B.C. Jacobs, P.A. van Doorn, J.H.J. Wokke, J.G.J. van de Winkel, J.H.W. Leusen, W-L. van der Pol. Anti-GM1 IgG antibodies induce leukocyte effector functions via Fcg Receptors. Annals of Neurology 2003: 53; 570-9. (http://www.ncbi.nlm.nih.gov/pubmed/12730990)

A.B. van Spriel, I. van den Herik-Oudijk, N.M. van Sorge, H.A. Vilé, J.A. van Strijp, J.G.J. van de Winkel. Effective phagocytosis and killing of Candida Albicans via targeting FcgRI (CD64) or FcaRI (CD89) on neutrophils. Journal of Infectious Diseases 1999: 179; 661-669. (http://www.ncbi.nlm.nih.gov/pubmed/9952373)

Book chapter

N.M. van Sorge, L.H. van den Berg, M.D. Jansen, J.G.J. van de Winkel, W-L. van der Pol.

Infection and Guillain-Barré syndrome. Chapter in Y. Shoenfeld and N. Rose (Eds.), ‘Infections and Autoimmunity’, ElsevierScience, Amsterdam, 2004.